Biosceptre’s Phase 1 Clinical Trial for anti-cancer antibody BIL03s approved by Ethics Committee
Biosceptre’s proposed Phase I clinical trial for BIL03s (anti-cancer monoclonal [...]
Biosceptre’s proposed Phase I clinical trial for BIL03s (anti-cancer monoclonal [...]
Biosceptre has published a clinical study demonstrating that its topical [...]